Francesco Modestino
Papers
1
Total Citations
27
H-Index
1
About
Francesco Modestino is a urologic surgeon and researcher whose work centers on the comparative effectiveness of minimally invasive treatments for kidney cancer, with a particular focus on small renal masses. His major contribution lies in rigorously evaluating whether percutaneous ablation can match the oncologic outcomes of partial nephrectomy for cT1a tumors. In his most cited work, a 2021 propensity score-matched analysis (27 citations), Modestino directly compared these two approaches, helping to clarify which patients might safely avoid surgery without compromising cancer control. This study is pivotal for shared decision-making, offering evidence that ablation can be a viable alternative for appropriately selected patients. Beyond this landmark paper, Modestino’s broader research portfolio continues to refine treatment algorithms for renal cell carcinoma, emphasizing personalized, kidney-sparing strategies. His work has been instrumental in moving the field toward less invasive paradigms, and his findings are frequently cited in clinical guidelines. For students and researchers, Modestino exemplifies how careful comparative effectiveness research can translate directly into improved, patient-centered urologic oncology care.
Research Focus
Key Achievements
Top Papers
- 1